SEC Tracker
Get the app

City Therapeutics CTY

City Therapeutics (CTY) - AVF XII acquires shares

Ownership stake disclosure

Form
Schedule 13D
Filed
Importance
Notable
  1. AVF XII purchased 2,027,006 shares of Series B Preferred Stock at $13.32 per share on May 20, 2026.
  2. AVF XII bought 170,000 shares of Common Stock at $18.00 per share on October 19, 2026.
  3. AVF XII's total investment in the company is $30,059,985.76.

Written from the Schedule 13D on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when City Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float not reported.

  1. Acura Pharmaceuticals ACUR
  2. Ayala Pharmaceuticals ADXS
  3. Ampio Pharmaceuticals AMPE
  4. Alterity Therapeutics ATHE
  5. Adhera Therapeutics ATRX